Cancer Center Research Programs
The UVA Cancer Center has approximately 160 Full and Associate Members divided into five Research Programs. Each of these Programs represents an area of genuine expertise important for understanding cancer initiation and progression and for development of interventions to detect, diagnose, treat, and prevent cancer. Each Program has a natural affinity and identity, with sub-groups that make sense scientifically. In addition, each of these Programs has helped generate major discoveries important for cancer:
The Cancer Cell Signaling Program supported research that led to the discovery of MAP Kinase and FAK, and is supporting the application of cell signaling expertise to drug discovery.
The Chemical and Structural Biology Program has solved the structures of several proteins of key importance for cancer, including Rho-GDI and RUNX proteins, and is using this information for drug discovery and development.
The Molecular Genetics and Epigenetics Program was the origin of the discovery of the "histone code" and is nationally regarded as a premiere program for the study of chromatin and epigenomics.
The Women's Oncology Program investigators are involved in identifying molecular indicators of response in novel therapies in breast and gynecological cancers. In addition, investigators in this Program have lead roles in the National Cancer Institute's Gynecological Oncology Group (GOG), responsible for developing new therapies for women with gynecological malignancies.